相关实验视频
Updated: Jun 20, 2025

05:48
Rapid Generation of Amyloid from Native Proteins In vitro
Published on: December 5, 2013
6.2K
探索抗微生物和粉样之间的病理联系
Yijing Tang1, Yanxian Zhang2, Dong Zhang3
1Department of Chemical, Biomolecular, and Corrosion Engineering, The University of Akron, Ohio 44325, USA. zhengj@uakron.edu.
Chemical Society reviews
|July 23, 2024
概括
粉样蛋白 (AMYs) 和抗微生物 (AMPs) 具有共同的结构特征,使神经退行性疾病和感染中的交叉对话成为可能. 了解这种相互作用可能会为这两种疾病带来新的治疗方法.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 病理学 病理学 病理学
背景情况:
- 氨基酸 (AMY) 和抗菌 (AMP) 是不同的家族.
- 新出现的证据将AMY和AMP与神经退行性疾病和微生物感染联系起来.
- 在AMY和AMP之间存在共同的结构和功能特征.
研究的目的:
- 审查AMY和AMP之间相互作用的最新发展.
- 检查AMY-AMP相互作用在疾病中的病理影响.
- 突出挑战,并激励未来在这个领域的研究.
主要方法:
- 关于AMY-AMP相互作用的现有研究的文献综述.
- 分析共享的结构和功能特性.
- 讨论交叉播种现象和双向通信.
主要成果:
- AMYs可以表现出抗微生物活性,AMP可以表现出amyloidogenic属性.
- AMYs和AMPs之间的交叉播种是疾病发病的一个关键因素.
- 这种相互作用影响了神经退行和宿主防御机制.
结论:
- AMY和AMP之间的分子交叉对传染病和神经退行性疾病至关重要.
- 需要进一步的研究才能充分理解这些相互作用.
- 这种知识可以导致针对多种疾病的创新治疗策略.
更多相关视频
04:41Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
Published on: July 14, 2010
23.2K
10:19Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
Published on: August 14, 2016
9.3K
相关概念视频
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
Alzheimer's Disease: Overview
456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456